Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs
Reported by CNBC · cnbc.com · August 4, 2026
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.
What the tape says
What to watch: Pfizer Inc. (PFE) raised guidance toward $4 billion — confirm the raise reflects durable demand, not a one-time item.
Market reaction today: $PFE -0.36%
Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish CNBC's reporting.
Your read
Discussion
No one has weighed in yet. Start the discussion on this story.
Headline and link are attributed to CNBC. Wook of Wall Street is an independent research tool and is not affiliated with CNBC. Nothing here is financial advice or a recommendation — research and educational content only.